123 related articles for article (PubMed ID: 10571153)
1. 6-oxa isosteres of anacardic acids as potent inhibitors of bacterial histidine protein kinase (HPK)-mediated two-component regulatory systems.
Kanojia RM; Murray W; Bernstein J; Fernandez J; Foleno BD; Krause H; Lawrence L; Webb G; Barrett JF
Bioorg Med Chem Lett; 1999 Oct; 9(20):2947-52. PubMed ID: 10571153
[TBL] [Abstract][Full Text] [Related]
2. Multiple mechanisms of action for inhibitors of histidine protein kinases from bacterial two-component systems.
Hilliard JJ; Goldschmidt RM; Licata L; Baum EZ; Bush K
Antimicrob Agents Chemother; 1999 Jul; 43(7):1693-9. PubMed ID: 10390224
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effects of anacardic acids and methicillin against methicillin resistant Staphylococcus aureus.
Muroi H; Nihei K; Tsujimoto K; Kubo I
Bioorg Med Chem; 2004 Feb; 12(3):583-7. PubMed ID: 14738968
[TBL] [Abstract][Full Text] [Related]
4. SAR studies of diaryltriazoles against bacterial two-component regulatory systems and their antibacterial activities.
Sui Z; Guan J; Hlasta DJ; Macielag MJ; Foleno BD; Goldschmidt RM; Loeloff MJ; Webb GC; Barrett JF
Bioorg Med Chem Lett; 1998 Jul; 8(14):1929-34. PubMed ID: 9873461
[TBL] [Abstract][Full Text] [Related]
5. Bacterial two-component signalling as a therapeutic target in drug design. Inhibition of NRII by the diphenolic methanes (bisphenols).
Domagala JM; Alessi D; Cummings M; Gracheck S; Huang L; Huband M; Johnson G; Olson E; Shapiro M; Singh R; Song Y; Van Bogelen R; Vo D; Wold S
Adv Exp Med Biol; 1998; 456():269-86. PubMed ID: 10549373
[No Abstract] [Full Text] [Related]
6. Novel streptopyrroles from Streptomyces rimosus with bacterial protein histidine kinase inhibitory and antimicrobial activities.
Trew SJ; Wrigley SK; Pairet L; Sohal J; Shanu-Wilson P; Hayes MA; Martin SM; Manohar RN; Chicarelli-Robinson MI; Kau DA; Byrne CV; Wellington EM; Moloney JM; Howard J; Hupe D; Olson ER
J Antibiot (Tokyo); 2000 Jan; 53(1):1-11. PubMed ID: 10724001
[TBL] [Abstract][Full Text] [Related]
7. Anti-Helicobacter pylori agents from the cashew apple.
Kubo J; Lee JR; Kubo I
J Agric Food Chem; 1999 Feb; 47(2):533-7. PubMed ID: 10563928
[TBL] [Abstract][Full Text] [Related]
8. Substituted salicylanilides as inhibitors of two-component regulatory systems in bacteria.
Macielag MJ; Demers JP; Fraga-Spano SA; Hlasta DJ; Johnson SG; Kanojia RM; Russell RK; Sui Z; Weidner-Wells MA; Werblood H; Foleno BD; Goldschmidt RM; Loeloff MJ; Webb GC; Barrett JF
J Med Chem; 1998 Jul; 41(16):2939-45. PubMed ID: 9685233
[TBL] [Abstract][Full Text] [Related]
9. Repurposing Hsp90 inhibitors as antibiotics targeting histidine kinases.
Vo CD; Shebert HL; Zikovich S; Dryer RA; Huang TP; Moran LJ; Cho J; Wassarman DR; Falahee BE; Young PD; Gu GH; Heinl JF; Hammond JW; Jackvony TN; Frederick TE; Blair JA
Bioorg Med Chem Lett; 2017 Dec; 27(23):5235-5244. PubMed ID: 29110989
[TBL] [Abstract][Full Text] [Related]
10. Characterization of xanthine oxidase inhibition by anacardic acids.
Masuoka N; Kubo I
Biochim Biophys Acta; 2004 Apr; 1688(3):245-9. PubMed ID: 15062875
[TBL] [Abstract][Full Text] [Related]
11. Zoosporicidal activities of anacardic acids against Aphanomyces cochlioides.
Begum P; Hashidoko Y; Islam MT; Ogawa Y; Tahara S
Z Naturforsch C J Biosci; 2002; 57(9-10):874-82. PubMed ID: 12440727
[TBL] [Abstract][Full Text] [Related]
12. Bacterial histidine kinases as novel antibacterial drug targets.
Bem AE; Velikova N; Pellicer MT; Baarlen Pv; Marina A; Wells JM
ACS Chem Biol; 2015 Jan; 10(1):213-24. PubMed ID: 25436989
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial agents that inhibit two-component signal transduction systems.
Barrett JF; Goldschmidt RM; Lawrence LE; Foleno B; Chen R; Demers JP; Johnson S; Kanojia R; Fernandez J; Bernstein J; Licata L; Donetz A; Huang S; Hlasta DJ; Macielag MJ; Ohemeng K; Frechette R; Frosco MB; Klaubert DH; Whiteley JM; Wang L; Hoch JA
Proc Natl Acad Sci U S A; 1998 Apr; 95(9):5317-22. PubMed ID: 9560273
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of a potent antibacterial agent, NH125 against drug-resistant bacteria.
Yamamoto K; Kitayama T; Ishida N; Watanabe T; Tanabe H; Takatani M; Okamoto T; Utsumi R
Biosci Biotechnol Biochem; 2000 Apr; 64(4):919-23. PubMed ID: 10830522
[TBL] [Abstract][Full Text] [Related]
15. Anacardic acid derived salicylates are inhibitors or activators of lipoxygenases.
Wisastra R; Ghizzoni M; Boltjes A; Haisma HJ; Dekker FJ
Bioorg Med Chem; 2012 Aug; 20(16):5027-32. PubMed ID: 22789707
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of inhibitors of the essential histidine kinase, YycG in Bacillus subtilis and Staphylococcus aureus.
Watanabe T; Hashimoto Y; Yamamoto K; Hirao K; Ishihama A; Hino M; Utsumi R
J Antibiot (Tokyo); 2003 Dec; 56(12):1045-52. PubMed ID: 15015732
[TBL] [Abstract][Full Text] [Related]
17. Novel cajaninstilbene acid derivatives as antibacterial agents.
Geng ZZ; Zhang JJ; Lin J; Huang MY; An LK; Zhang HB; Sun PH; Ye WC; Chen WM
Eur J Med Chem; 2015 Jul; 100():235-45. PubMed ID: 26093280
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial action of anacardic acids against methicillin resistant Staphylococcus aureus (MRSA).
Kubo I; Nihei K; Tsujimoto K
J Agric Food Chem; 2003 Dec; 51(26):7624-8. PubMed ID: 14664518
[TBL] [Abstract][Full Text] [Related]
19. Molecular design of anti-MRSA agents based on the anacardic acid scaffold.
Green IR; Tocoli FE; Lee SH; Nihei K; Kubo I
Bioorg Med Chem; 2007 Sep; 15(18):6236-41. PubMed ID: 17601740
[TBL] [Abstract][Full Text] [Related]
20. Histidine kinases as targets for new antimicrobial agents.
Matsushita M; Janda KD
Bioorg Med Chem; 2002 Apr; 10(4):855-67. PubMed ID: 11836091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
